Search arXiv⌕ Search
Home/Archive/arXiv

arXiv · 2403.14728

Investigation of Genomic Effect of Zirconium Oxide Nanoparticles in Escherichia coli Bacteria

Simin Rashidi·Bahram Golestani Eimani
View original source ↗Read source document ↗Export metadata ↓

Abstract

Due to the concerns of the society about the increase of antibiotic resistant infections, many studies and research have been done on nanoparticles and applications of nano-biotechnology. Zirconium Oxide ($\text{ZrO}_{2}$) in which called zirconia, is a white oxide of zirconium metal that its diameter is 20 nm. The colloidal size of these particles is often smaller than bacterial and eukaryotic cells. The main intention of this paper is to investigate the effect of different doses of $\text{ZrO}_{2}$ NPs on the sequences changes for the $\textit{Escherichia coli}$ ($\textit{E. coli}$) genome. At the first step, $\textit{E. coli}$ was cultured in eosin methylene blue agar and brain heart broth (BHB) mediums, respectively. Then, bacteria were treated with $\text{ZrO}_{2}$ NPs at concentrations of 100, 250, and 350 $\mu$g/ml. After treatment, the growth of bacteria was evaluated by utilizing spectrophotometry at 600 nm after incubation times including 2, 4, 6, 8, and 24 hours at 37 $^{\circ}$C. At the second step, the extraction of DNA was performed by using control and treated samples. Then, the changes in the sequence of bacterial genome were investigated using RAPD markers. Finally, NTSYS-PC platform was employed in order to analyze of the results extracted by electrophoresis of products on agarose gel. In this paper, it was observed that $\text{ZrO}_{2}$ NPs can inhibit the growth of bacteria at concentrations of 250 and 350 $\mu$g/ml after 8 hours of treatment. It was also found that the $\text{ZrO}_{2}$ NPs at different concentrations have not changed the genome sequence of $\textit{E. coli}$. Furthermore, it was concluded that the $\text{ZrO}_{2}$ NPs with the concentration of 350 $\mu$g/ml had the highest inhibitory properties without significant changing in the genomic sequence of $\textit{E. coli}$.

Explore related subjects

q-bio.OT

Keep this discovery

BibTeXRIS

Simin Rashidi, Bahram Golestani Eimani. 2024-03-21. Investigation of Genomic Effect of Zirconium Oxide Nanoparticles in Escherichia coli Bacteria. https://arxiv.org/abs/2403.14728

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT↗
arXiv2026

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT↗
arXiv2026

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT↗